There is a new name in the very lucrative surgical robotics space -- Titan -- and it wants a piece of Intuitive Surgical's (NASDAQ:ISRG) market. Titan's business model will be very familiar for anyone who knows Intuitive Surgical: Sell a robotic surgery platform to health care facilities, and then design and sell tools for that robot designed to perform specific procedures. It has even named its robot Amadeus, paying tribute to Mozart in the way that Intuitive's da Vinci robot is a nod to Leonardo da Vinci. So if Titan can beat Intuitive's prices, should investors be worried? In this video, Motley Fool analyst Brenton Flynn tells us how these fears are a long way off and a lot needs to happen first. But, he warns, keep an eye on Titan, just in case.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.